A poorly understood aspect of cognitive aging is the association between cardiac output and brain aging. Clinical and epidemiological data suggest that after vascular risk factors are accounted for, very modest reductions in cardiac output are cross-sectionally associated with worse cognitive performance, 1 smaller brain volumes, 2 white matter hyperintensities, 3 and reduced normative cerebral perfusion values in regions of white matter injury. 4 These observations may be due to subclinical systemic blood flow disrupting cerebral blood flow homeostasis, especially among older adults with compromised cerebral circulation control mechanisms.
Methods

Participants
The Framingham Offspring Study design has been previously described. 9 From 1971 to 1975, 5124 participants were recruited and have been examined approximately every 4 years since. The present sample was derived from 3539 participants attending the seventh examination cycle (1998) (1999) (2000) (2001) , of whom 1677 consented to undergo cardiac magnetic resonance imaging between 2002 and 2006. Figure 1 summarizes the inclusion and exclusion criteria for the present study. The study protocol was approved by the local Institutional Review Board, and participants provided written informed consent before assessments.
Cardiac Index Measurement
The Framingham Heart Study cardiac magnetic resonance imaging protocol has been reported elsewhere. 2, 10, 11 Briefly, supine imaging was performed on a Philips 1.5-T scanner with a 5-element commercial cardiac array coil. End-expiratory breath-hold, ECG-gated, cine steady-state free-precession images were acquired in 2-chamber, 4-chamber, and contiguous short-axis orientations (temporal resolution, 39 milliseconds; repetition time, R-R interval; echo time, 9 milliseconds; flip angle, 30°; field of view, 400 mm; matrix size, 208×256; slice thickness, 10 mm; gap, 0 mm). Analyses were performed by an experienced reviewer blinded to clinical information using a clinical workstation (EasyVision 5.1, Philips Medical Systems). End-diastolic volume (EDV) was determined as the minimal crosssectional area of a midventricular slice. EDV and end-systolic volume (ESV) were computed by the summation-of-disks method with cardiac output (L/min) calculated as follows: (EDV−ESV)×heart rate. Cardiac output was divided by body surface area to calculate cardiac index (L·min −1 ·m −2 ). The interrater reliability correlation coefficient for EDV was 0.95 and for ESV was 0.92. The intraobserver coefficient of variation for EDV was 2.6% and for ESV was 3.5%. 12 The interobserver coefficient of variation for EDV was 3.5% and for ESV was 4.8%.
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Incident Dementia and AD Case Definition
Starting at cycle examination 5 (beginning in 1991), Offspring participants have been systematically monitored at each cycle examination for the development of dementia. Such monitoring includes a cognitive concern by the participant, a family member, or a Framingham study physician or staff member (including concerns about neuropsychological performance) or a Mini-Mental State Examination 13 score below an education-based cutoff, 3 points worse than a preceding examination (after cycle examination 5), or a 5-point decrement overall (after cycle examination 5), which triggers more in-depth testing. 14, 15 All available neurological examination results, neuropsychological assessment results, study records, hospital records, primary care physician records, neuroimaging records, family interview information, and autopsy results are reviewed by a panel that includes at least 1 neurologist and at least 1 neuropsychologist to adjudicate dementia cases, diagnosis dates, and subtypes. Standard diagnostic criteria are used to define dementia 16 ; in addition, Framingham criteria require dementia severity to be equivalent to or greater than a Clinical Dementia Rating 17 global score of 1 and for symptoms to have been present for a minimum of 6 months. AD-type dementia is defined with the use of standard criteria and includes probable and possible AD.
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Covariates
Covariates were defined at the seventh examination cycle unless otherwise noted. Education was defined categorically, including no high school degree, high school degree but no college, some college but no college degree, or a college degree. The Framingham Stroke Risk Profile score included age, sex, systolic blood pressure, antihypertensive medication, diabetes mellitus, cigarette smoking, left ventricular hypertrophy, CVD history, and atrial fibrillation. Systolic blood pressure was the mean of 2 measurements obtained during the examination by a Framingham Heart Study physician. Diabetes mellitus included previous or current fasting blood glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, or previous or current use of oral hypoglycemic or insulin. Current cigarette smoking (ie, yes/no within the year before examination 7) and medication use were ascertained by self-report. Prior CVD (ie, coronary heart disease, angina, coronary insufficiency, myocardial infarction, heart failure, intermittent claudication) was defined at the time of cardiac Apolipoprotein E (APOE) genotyping was determined by polymerase chain reaction amplification and restriction isotyping. 20 
Statistical Analysis
For hypothesis testing, Cox proportional hazard regression models examined the association between cardiac index and incident dementia in 2 models that included covariates based on prior work. 21, 22 Model 1 adjusted for age (years), sex, and education (categorical). Model 2 adjusted for Framingham Stroke Risk Profile (which assigns points for age by sex), education, and APOE allele 4 (APOE4) status (ie, ε4 negative versus ε4 positive 23 ). Models were repeated, restricting the outcome to AD-type dementia. A second set of primary analyses repeated the models above, treating cardiac index as a categorical variable to align with clinical cut points of cardiac index. That is, models examined the relative risk of incident dementia between participants with clinically low cardiac index (defined 24, 25 as <2.5 L·min −1 ·m −2 ) and normal cardiac index (referent). Again, models were repeated, restricting the outcome to AD-type dementia. Secondary analyses were performed on all models, excluding participants with prevalent CVD (n=145) and atrial fibrillation (n=66). These exclusions resulted in 5 fewer cases of dementia (including 4 fewer cases of AD) for analyses. Significance was set at P<0.05. Data were analyzed with SAS version 9.2 (SAS Institute Inc, Cary, NC).
Results
Participant Characteristics
The mean sample age was 69±6 years (range, 60-89 years), and 53% were women. Cardiac index was normally distributed in the sample, and low cardiac index (ie, <2.5 L·min 24 was present in 33% of participants (n=341). After the exclusion of individuals with prevalent CVD, low cardiac index was present in 31% of the sample (n=269). Over the median follow-up period of 7.7 years (range, 0-11 years), 32 participants developed dementia, including 26 AD cases. Table 1 summarizes clinical characteristic details for participants included in and excluded from the present analysis.
Continuous Cardiac Index
In models adjusting for age, sex, and education, each 1 Table 2 ). When participants with prevalent CVD and atrial fibrillation (n=184) were excluded from the analyses, cardiac index was still significantly associated with incident dementia and AD (Table 2) .
Categorical Cardiac Index
In models adjusting for age, sex, and education, participants with impaired cardiac index had a higher risk of dementia (HR=2. 15 Table 2 provides model details, and Figure 2 shows an illustration of categorical results using survival curves estimated from Cox regression at the mean of the covariates (age, sex, and education) for low cardiac index and normal cardiac index. When participants with prevalent CVD and atrial fibrillation were excluded, participants with impaired cardiac index had an increased relative risk of both dementia (HR=2.92; 95% CI, 1.34-6.36; P=0.007) and AD (HR=2.87; 95% CI, 1.21-6.80; P=0.016; Table 2 ) compared with participants with normal cardiac index.
Discussion
Among community-dwelling adults ≥60 years of age, we found that cardiac index is associated with incident dementia and AD over a median follow-up period of 7.7 years. That is, per 1-SD unit decrease in cardiac index, the relative risk of incident dementia and AD increased. When cardiac index was examined categorically, participants with clinically low cardiac index had a >2-fold increased risk of developing dementia compared with participants with normal cardiac index. When participants with prevalent CVD and atrial fibrillation were excluded, participants with clinically low cardiac index had a nearly 3-fold increased risk of developing both dementia and AD compared with the referents.
Our data are among the first to demonstrate that low cardiac index is related to an increased relative risk of incident dementia and AD in a community-based cohort. The present findings extend our prior cross-sectional research relating cardiac index to neuroimaging phenotypes of AD, including reduced total brain volume and increased lateral ventricular volume. 2 Furthermore, our secondary models suggest that prevalent CVD and atrial fibrillation do not statistically explain the significant observations in our primary models.
The mechanisms underlying our observations are unknown and likely multifactorial. Human studies suggest that autoregulation of cerebral blood velocity in the macrovasculature is preserved in acute settings of orthostatic hypotension. 26, 27 However, there is limited research assessing cerebral blood flow or perfusion regulation in the setting of chronic reduction (the exception being the extreme clinical model of heart failure 28, 29 ). Animal research suggests that autoregulatory mechanisms for maintaining cerebral blood flow may not function reliably when cardiac output is manipulated, 30 especially in the presence of cerebrovascular injury. 31 Therefore, we speculate that one mechanism accounting for our findings is compromised cerebral autoregulation or control mechanisms whereby subtle, chronic reductions in systemic hemodynamics over time disrupt cerebral blood flow in the microvasculature. Such changes could place the brain at greater risk for cerebrovascular and neurodegenerative processes, especially in the presence of concomitant age-related changes in blood-brain barrier permeability 32 and vascular compliance. 33, 34 Furthermore, compromised cerebrovascular health has been shown to propagate amyloid deposition, 35, 36 is associated with compromised β-amyloid clearance, [37] [38] [39] and contributes to faster clinical manifestation 40, 41 and trajectory 42, 43 of AD. Thus, systemic hemodynamics may affect cerebral hemodynamics in those older adults who have compromised cerebral circulation control mechanisms and contribute to the pathogenesis or exacerbation of amyloid deposition and subsequent neuronal injury. That being said, we cannot rule out other possible mechanisms, an epiphenomenon not captured by our covariates, residual confounding, or chance.
Consistent with our prior work in the Framingham Heart Study, 2 it is notable that one third of our cohort had cardiac index values below a clinical threshold for abnormal cardiac function (<2.5 L·min −1 ·m −2 ). One explanation is that prevalent CVD may have contributed to cardiac dysfunction, resulting in lower cardiac index values. However, the prevalence of low cardiac index was similar when participants with prevalent CVD were excluded, suggesting that the low cardiac index seen in our cohort is not explained by clinical heart disease. It is plausible that age-related changes in left ventricular diastolic filling such as reduced contribution of early atrial filling, impaired left ventricular compliance, or reduced preload may have contributed to reductions in cardiac output. 44, 45 Additional research is warranted to identify the mechanisms underlying lower cardiac index in ambulatory older adults, especially if future research replicates the present findings that low cardiac index is a risk factor for incident dementia and AD.
Previous work suggests that vascular risk factors modestly increase the risk of AD. For example, hypertension is related to a 1.4-fold increase in incident AD, 46 whereas diabetes mellitus is related to a 2.4-fold increased risk, 46 especially among APOE4-negative elders (HR=2.7). 7 In the present study, we report that lower cardiac index increases the relative risk of dementia and AD by ≈2-fold when we exclude people with prevalent CVD and atrial fibrillation and adjust for key demographic, environmental, and genetic risk factors related to AD, including age, sex, education, systolic blood pressure, diabetes mellitus, prevalent CVD, and APOE4 status. [6] [7] [8] 21, 22, 46 Our study has several strengths, including the large community-based cohort free of clinical dementia and stroke at baseline, comprehensive ascertainment of potential confounders, a precise cardiac imaging technique for quantifying cardiac output in epidemiological cohorts, stringent quality control procedures for cardiac measurement and dementia surveillance, and a core laboratory for processing measurements. However, the present findings must be tempered by several caveats. The racial makeup of the Framingham Offspring Study is white, so the generalizability to other races and ethnicities is unknown. Similarly, whether our results are relevant to individuals <60 years of age is unknown. Despite the effect size of our findings, it is imperative to highlight the very small number of incident cases as a major limitation to the present methods. There are only 26 dementia cases in total, including 21 cases of AD, which may be due to less sensitive dementia surveillance methods (eg, using impaired cross-sectional MiniMental State Examination performances or performance decrements over time to trigger a more in-depth assessment). It is also a noteworthy limitation that we relied on more traditional criteria for diagnosing dementia and AD rather than more recent criteria such as recommendations put forth by the National Institute on Aging and Alzheimer's Association Workgroup. 47 Our methodology also did not include neuroimaging measures of cerebral blood flow, cerebrovascular reactivity, or vascular stiffness, which limits our ability to explain the mechanism(s) underlying our observations. Finally, we cannot exclude the possibility of residual confounding or chance. The stability of associations reported here and their magnitude should be interpreted with caution until future studies can replicate our findings.
Conclusions
Resting cardiac index is associated with risk for incident dementia and AD, including individuals free of prevalent CVD and atrial fibrillation. We propose that subtle reductions in cardiac index are associated with an accelerated pathophysiology of dementia and AD in particular. Further investigation into the mechanisms underlying this increased risk is merited for identifying targets for primary prevention purposes or therapeutic interventions.
